Cargando…

Single cell metrics of the efficacy of CAR T cells

Detalles Bibliográficos
Autores principales:	Romain, Gabrielle, Singh, Harjeet, Liadi, Ivan, Adolacion, Jay R, Roysam, Badrinath, Cooper, Laurence, Varadarajan, Navin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649306/ http://dx.doi.org/10.1186/2051-1426-3-S2-P324

Ejemplares similares

Quantitative single-cell characterization of CAR+ T cell effector functions
por: Liadi, Ivan, et al.
Publicado: (2013)

Functional and molecular characterization of single serial killer CAR+ T cells demonstrates adaptive modification of behavior and fate based on tumor cell density
por: Varadarajan, Navin, et al.
Publicado: (2014)

Single-cell motility and gene expression signature as predictors of the overall survival of act in melanoma patients
por: Martinez-Paniagua, Melisa, et al.
Publicado: (2015)

Designed improvement to T-cell immunotherapy by multidimensional single cell profiling
por: Bandey, Irfan N, et al.
Publicado: (2021)

Single-cell profiling of dynamic cytokine secretion and the phenotype of immune cells
por: An, Xingyue, et al.
Publicado: (2017)

Single-cell quantification of functional outcomes of CD16 ligation in NK cells by Fc-engineered antibodies
por: Romain, Gabrielle, et al.
Publicado: (2013)

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses
por: Romain, Gabrielle, et al.
Publicado: (2022)

Chimeric antigen receptor (CAR)+ T cell selection method affects transgene efficacy
por: Rushworth, David, et al.
Publicado: (2013)

Automated detection of apoptotic bodies and cells in label-free time-lapse high-throughput video microscopy using deep convolutional neural networks
por: Wu, Kwan-Ling, et al.
Publicado: (2023)

Single-Cell Cloning of Breast Cancer Cells Secreting Specific Subsets of Extracellular Vesicles
por: Fathi, Mohsen, et al.
Publicado: (2021)

Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies
por: Smith, Jenessa B, et al.
Publicado: (2015)

Il-6 is non-essential to murine CD19 CAR efficacy, but can mediate acute GVHD following allogeneic BMT with CAR T cell infusion
por: Jacoby, Elad, et al.
Publicado: (2015)

Enhancing T cell persistence of CAR-redirected T cells in solid tumors
por: Guedan, Sonia, et al.
Publicado: (2014)

Chimeric antigen receptors (CARs) incorporating mutations in the IgG4 Fc spacer region to eliminate Fc receptor recognition results in improved CAR T cell persistence and anti-tumor efficacy
por: Jonnalagadda, Mahesh, et al.
Publicado: (2013)

Go-CART: an animal-free system for the assessment of CAR T cell function
por: Bajgain, Pradip, et al.
Publicado: (2015)

Development of anti-GPC-1 (glypican-1)-CAR-T cells for adoptive T cell immunotherapies for squamous cell carcinoma
por: Yaguchi, Tomonori, et al.
Publicado: (2015)

Targeting FRβ+ tumor associated macrophages with car T cells in ovarian cancer
por: Lynn, Rachel C, et al.
Publicado: (2015)

Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells
por: Mannioui, Cécile Schiffer, et al.
Publicado: (2013)

Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer
por: Gerdts, Ethan, et al.
Publicado: (2015)

A new spike train metric
por: Rusu, Cătălin V, et al.
Publicado: (2010)

Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma
por: Brown, Christine E, et al.
Publicado: (2015)

Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials
por: Jena, Bipulendu, et al.
Publicado: (2013)

Dejittering of neural responses by use of their metric properties
por: Dimitrov, Alexander G, et al.
Publicado: (2011)

MyD88/CD40-based inducible co-stimulation to improve CAR T cell therapy
por: Mata, Melinda, et al.
Publicado: (2015)

Spike train distance metric reveals plasticity in discrimination of salient calls by putative excitatory cells of the auditory cortex
por: Zhao, Charles L, et al.
Publicado: (2012)

Metrics of arterial hyperoxia and associated outcome in critical care
por: Helmerhorst, HJF, et al.
Publicado: (2015)

Single-cell RNA-seq analysis reveals compartment-specific heterogeneity and plasticity of microglia
por: Zheng, Junying, et al.
Publicado: (2021)

A BCMA-specific CAR T cell produced with clinically scalable lentiviral and T cell manufacturing processes has potent anti-multiple myeloma activity
por: Garrett, Tracy E, et al.
Publicado: (2015)

Adaptive matrix metrics for molecular descriptor assessment in QSPR classification
por: Soto, Axel J, et al.
Publicado: (2010)

Optimizing genotype quality metrics for individual exomes and cohort analysis
por: Gordon, Paul MK, et al.
Publicado: (2012)

Automated image computing reshapes computational neuroscience
por: Peng, Hanchuan, et al.
Publicado: (2013)

Restrictive parenteral fluid therapy in infants and children presenting with acute severe viral pneumonia in the PICU: a single-center experience
por: Kandasamy, S, et al.
Publicado: (2014)

Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246)
por: Walker, Alec, et al.
Publicado: (2014)

Charachterization and functional analysis of scFv-based CARs to redirect T cells to IL13Rα2-positive glioma
por: Krenciute, Giedre, et al.
Publicado: (2015)

A metric space approach to the information channel capacity of spike trains
por: Gillespie, James B, et al.
Publicado: (2011)

Quantitative texture features as objective metrics of enhancement heterogeneity in hypertrophic cardiomyopathy
por: Thornhill, Rebecca E, et al.
Publicado: (2014)

P1441: SINGLE-CELL TRANSCRIPTOMIC CHARACTERIZATIONS OF BONE MARROW MONONUCLEAR CELLS AND CAR-T PRODUCTS ASSOCIATED WITH EFFICACY AND TOXICITY IN B-ALL PATIENTS
por: Du, M., et al.
Publicado: (2022)

Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
por: Brown, Christine E, et al.
Publicado: (2013)

Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
por: Park, Anthony K, et al.
Publicado: (2015)

NetMets: software for quantifying and visualizing errors in biological network segmentation
por: Mayerich, David, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_do66qgp6g6o2jpoktlo6tecgun